Personalized medicine in COPD treatment-Reference-Cited by-同舟云学术

Personalized medicine in COPD treatment

Published:2014-07-02 Issue:3 Volume:3 Page:133-139
ISSN:2161-332X
Container-title:Current Respiratory Care Reports
language:en
Short-container-title:Curr Respir Care Rep

Author:

Shen Ning,He Bei

Publisher

Springer Science and Business Media LLC

Subject

General Engineering

Link

http://link.springer.com/content/pdf/10.1007/s13665-014-0085-1.pdf

Reference34 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: revised 2014. Available from: http://www.goldcopd.org . GOLD is the most important document of COPD, and the new version of GOLD is a tentative move towards personalized treatment for patients with COPD.

2. Han MK et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598–604. This clinical commentary gave a clear definition of COPD phenotype, and proposed that COPD phenotypes should be associated with clinically meaningful outcomes. This more focused definition allows for classification of patients into distinct prognostic and therapeutic subgroups for both clinical and research purposes.

3. Burrows B et al. The emphysematours and bronchial types of chronic airways obstruction. Lancet. 1966;1:830.

4. Weiss ST, Speizer FE. Increased levels of airways responsiveness as a risk factor for development of chronic obstructive lung disease: what are the issues? Chest. 1984;86:3.

5. Kim V et al. COPDGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPD gene study. Chest. 2011;140:626–33.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights;Expert Review of Respiratory Medicine;2016-02-15